Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Jason F Okulicz"'
Autor:
Jason M Blaylock, Evan C Ewers, Elizabeth J Bianchi, David B King, Rosemary O Casimier, Hector Erazo, Stephen Grieco, Jenny Lay, Sheila A Peel, Kayvon Modjarrad, Charmagne G Beckett, Jason F Okulicz, Paul T Scott, Shilpa Hakre
Publikováno v:
PLoS ONE, Vol 18, Iss 12, p e0296054 (2023)
BackgroundThe evidence for an increased incidence of sexually transmitted infections (STIs) among patients utilizing HIV pre-exposure prophylaxis (PrEP) has been inconsistent. We assessed the risk of incident STI while on PrEP compared to periods off
Externí odkaz:
https://doaj.org/article/9075845873ae4f8caa2022fa5c81b17c
Autor:
Jason M Cota, Taylor M Benavides, John D Fields, Nathan Jansen, Anuradha Ganesan, Rhonda E Colombo, Jason M Blaylock, Ryan C Maves, Brian K Agan, Jason F Okulicz
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250607 (2021)
ObjectivesWe sought to determine the prevalence of phosphodiesterase type 5 inhibitor (PDE-5) mediated drug-drug interactions (DDIs) in males with HIV infection receiving antiretroviral therapy (ART) and identify factors associated with PDE-5-mediate
Externí odkaz:
https://doaj.org/article/b77ac608004b4c3eb908b71015873297
Autor:
Leonard Emuren, Seth Welles, Alison A Evans, Marcia Polansky, Jason F Okulicz, Grace Macalino, Brian K Agan, Infectious Disease Clinical Research Program HIV Working Group
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178953 (2017)
The aims of this study were: (i) to determine the factors associated with HRQOL at baseline in our cohort, and (ii) to evaluate if there are differences in baseline HRQOL measures by antiretroviral treatment.The Short Form 36 (SF-36) was administered
Externí odkaz:
https://doaj.org/article/8dbd0446c0894d12bbc4bde8e309c6aa
Autor:
Trevor A Crowell, Anuradha Ganesan, Stephen A Berry, Robert G Deiss, Brian K Agan, Jason F Okulicz, for the Infectious Disease Clinical Research Program (IDCRP) HIV Working Group
Publikováno v:
Journal of the International AIDS Society, Vol 19, Iss 1, Pp n/a-n/a (2016)
Introduction HIV controllers (HICs) experience relatively low‐level viraemia and CD4 preservation without antiretroviral therapy (ART), but also immune activation that may predispose to adverse clinical events such as cardiovascular disease and hos
Externí odkaz:
https://doaj.org/article/4a285241689a44409725105171dbd40b
Autor:
William F Flynn, Max W Chang, Zhiqiang Tan, Glenn Oliveira, Jinyun Yuan, Jason F Okulicz, Bruce E Torbett, Ronald M Levy
Publikováno v:
PLoS Computational Biology, Vol 11, Iss 4, p e1004249 (2015)
While the role of drug resistance mutations in HIV protease has been studied comprehensively, mutations in its substrate, Gag, have not been extensively cataloged. Using deep sequencing, we analyzed a unique collection of longitudinal viral samples f
Externí odkaz:
https://doaj.org/article/2c755f76f6a4487586e7afbbfde7fc7d
Autor:
Shilpa Hakre, Dariusz G Mydlarz, Peter Dawson, Patrick J Danaher, Philip L Gould, Catherine T Witkop, Nelson L Michael, Sheila A Peel, Paul T Scott, Jason F Okulicz
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126700 (2015)
ObjectiveThe objectives of this study were to describe the epidemiology of HIV in the United States Air Force (USAF) from 1996 through 2011 and to assess whether socio-demographic characteristics and service-related mobility, including military deplo
Externí odkaz:
https://doaj.org/article/a1912da46c804e6bb79ec58672e42ec8
Publikováno v:
Journal of the International AIDS Society, Vol 17, Iss 1, Pp n/a-n/a (2014)
Introduction Delayed‐type hypersensitivity (DTH) testing is an in vivo assessment of cell‐mediated immunity. Although highly active antiretroviral therapy (HAART) improves immunologic parameters, the relationship between DTH responsiveness and CD
Externí odkaz:
https://doaj.org/article/fe72d998873843beb88e02355f57ea96
Autor:
Jason F Okulicz, Octavio Mesner, Anuradha Ganesan, Thomas A O'Bryan, Robert G Deiss, Brian K Agan
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105591 (2014)
BackgroundHepatitis B virus (HBV) vaccine responsiveness is associated with reduced risk of AIDS or death in HIV-infected individuals. Although HIV controllers (HIC) typically have favorable immunologic and clinical characteristics compared to non-co
Externí odkaz:
https://doaj.org/article/c35c02ca17ed45088f223583ce0b763d
Autor:
Michael L Landrum, Katherine Huppler Hullsiek, Robert J O'Connell, Helen M Chun, Anuradha Ganesan, Jason F Okulicz, Tahaniyat Lalani, Amy C Weintrob, Nancy F Crum-Cianflone, Brian K Agan, Infectious Disease Clinical Research Program HIV Working Group
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33488 (2012)
BackgroundWhether seroresponse to a vaccine such as hepatitis B virus (HBV) vaccine can provide a measure of the functional immune status of HIV-infected persons is unknown.This study evaluated the relationship between HBV vaccine seroresponses and p
Externí odkaz:
https://doaj.org/article/06a2c8bb9b35493f8f0f10b0cfbd940f
Autor:
Elizabeth Hamlyn, Fiona M Ewings, Kholoud Porter, David A Cooper, Giuseppe Tambussi, Mauro Schechter, Court Pedersen, Jason F Okulicz, Myra McClure, Abdel Babiker, Jonathan Weber, Sarah Fidler, INSIGHT SMART and SPARTAC Investigators
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43754 (2012)
The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and onward transmission. We compared plasma viral load (pVL) rebound after stopping ART initiated in primary (PHI) and chronic HIV infection (CHI).Two po
Externí odkaz:
https://doaj.org/article/4a73ca6f3638441eb7838abdf15b1e8d